-
Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ Diabetes (IF 6.2) Pub Date : 2025-01-28 Shu Yang, Lijiao Xiong, Tingfeng Liao, Lixing Li, Yanchun Li, Lin Kang, Guangyan Yang, Zhen Liang
Insulin resistance, a hallmark of type 2 diabetes, accelerates muscle breakdown and impairs energy metabolism. However, the role of Ubiquitin Specific Peptidase 2 (USP2), a key regulator of insulin resistance, in sarcopenia remains unclear. Peroxisome proliferator activated receptor γ (PPARγ) plays a critical role in regulating muscle atrophy. This study investigates the role of deubiquitinase USP2
-
Identification of CD209 as an Intervention Target for Type 2 Diabetes after COVID-19 Infection: Insights from Proteome-wide Mendelian Randomization Diabetes (IF 6.2) Pub Date : 2025-01-28 Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi Jiang
Increasing evidence suggests that individuals infected with Coronavirus disease 2019 (COVID-19) are at a higher risk of developing type 2 diabetes (T2D) compared to those who are not infected. However, the mechanisms underlying this relationship remain poorly understood. In this study, we aimed to systematically evaluate the mediating roles of 3,283 plasma proteins in the link between COVID-19 susceptibility
-
An alternatively translated isoform of PPARG proposes AF-1 domain inhibition as an insulin sensitization target Diabetes (IF 6.2) Pub Date : 2025-01-24 Xiaomi Du, Karen Mendez-Lara, Siqi Hu, Rachel Diao, Guru Bhavimani, Ruben Hernandez, Kimberly Glass, Camila De Arruda Saldanha, Jason Flannick, Sven Heinz, Amit R. Majithia
PPARγ is the pharmacological target of thiazolidinediones (TZDs), potent insulin sensitizers that prevent metabolic disease morbidity but are accompanied by side effects such as weight gain, in part due to non-physiological transcriptional agonism. Using high throughput genome engineering, we targeted nonsense mutations to every exon of PPARG, finding an ATG in Exon 2 (chr3:12381414, CCDS2609 c.A403)
-
Extracellular vesicle-associated miR-ERIA exerts the anti-angiogenic effect of macrophages in diabetic wound healing Diabetes (IF 6.2) Pub Date : 2025-01-24 Tingting Zeng, Kan Sun, Lifang Mai, Xiaosi Hong, Xiaodan He, Weijie Lin, Sifan Chen, Li Yan
Many cell types are involved in the regulation of cutaneous wound healing in diabetes. Clarifying the mechanism of cell-cell interactions is important for identifying therapeutic targets for diabetic cutaneous ulcers. The function of vascular endothelial cells in the cutaneous microenvironment is critical, and a decrease in their biological function leads directly to refractory wound healing. In this
-
Homeobox C4 transcription factor promotes adipose tissue thermogenesis Diabetes (IF 6.2) Pub Date : 2025-01-24 Ting Yang, Yuxuan Wang, Hang Li, Fengshou Shi, Siqi Xu, Yingting Wu, Jiaqi Xin, Yi Liu, Mengxi Jiang
The homeobox (HOX) family has shown potential in adipose development and function, yet the specific HOX proteins fueling adipose thermogenesis remain elusive. In this study, we uncovered the novel function of HOXC4 in stimulating adipose thermogenesis. Our bioinformatic analysis indicated an enrichment of Hoxc4 co-expressed genes in metabolic pathways and linked HOXC4 polymorphisms to metabolic parameters
-
Mechanistic Insights Into the Exercise-Induced Changes in Muscle Lipids and Insulin Sensitivity—Expanding on the “Athlete’s Paradox”: Revisiting a 2011 Diabetes Classic by Amati et al. Diabetes (IF 6.2) Pub Date : 2025-01-21 Jeffrey F. Horowitz, Bret H. Goodpaster
Endurance exercise is widely recognized for its role in mitigating insulin resistance, yet the precise mechanisms remain unclear. In this Classics in Diabetes article, we revisit the article by Amati et al., “Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?” Published in the October 2011 issue of Diabetes, this article
-
A new model of experimental diabetic cardiomyopathy using combination of multiple doses of anomer-equilibrated streptozotocin and high fat diet: sex matters. Diabetes (IF 6.2) Pub Date : 2025-01-21 Loucia Karatzia, Fenn Cullen, Megan Young, Shing Hei Lam, Valle Morales, Katiuscia Bianchi, Sian M. Henson, Dunja Aksentijevic
Diabetes mellitus (DM) leads to a more rapid development of DM cardiomyopathy (dbCM) and progression to heart failure in women than men. Combination of high-fat diet (HFD) and freshly-injected streptozotocin (STZ) has been widely used for DM induction, however emerging data shows that anomer-equilibrated STZ produces an early onset and robust DM model. We designed a novel protocol utilising a combination
-
Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects Diabetes (IF 6.2) Pub Date : 2025-01-16 Anita C. Hohenstein, Joylynn Gallegos, Mylinh Dang, Jason Groegler, Hali Broncucia, Fatima Tensun, Kathleen Waugh, Fran Dong, Eddie A. James, Cate Speake, Andrea K. Steck, Marian J. Rewers, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong, Rocky L. Baker
Type 1 Diabetes (T1D) is an autoimmune disease mediated by autoreactive T cells. Our studies indicate that CD4 T cells reactive to Hybrid Insulin Peptides (HIPs) play a critical role in T cell-mediated beta-cell destruction. We have shown that HIPs form in human islets between fragments of the C-peptide and cleavage products of secretory granule proteins. To identify T cell specificities contributing
-
Cisplatin exposure dysregulates insulin secretion in male and female mice Diabetes (IF 6.2) Pub Date : 2025-01-14 Lahari Basu, Lili Grieco-St-Pierre, Ma. Enrica Angela Ching, John D. H. Stead, Antonio A. Hanson, Jana Palaniyandi, Erin P. van Zyl, Myriam P. Hoyeck, Kelsea S. McKay, Kyle A. van Allen, Hyojin Lee, Xiao-Qing Dai, Austin Bautista, Evgenia Fadzeyeva, Erin E. Mulvihill, Carole L. Yauk, Jan A. Mennigen, Patrick E. MacDonald, Jennifer E. Bruin
Cancer survivors have an increased risk of developing Type 2 diabetes compared to the general population. Patients treated with cisplatin, a common chemotherapeutic agent, are more likely to develop metabolic syndrome and Type 2 diabetes than age- and sex-matched controls. Surprisingly, the impact of cisplatin on pancreatic islets has not been reported. Our study aimed to determine if mouse islet function
-
Clonal haematopoiesis of indeterminate potential and risk of microvascular complications among individuals with type 2 diabetes: a cohort study Diabetes (IF 6.2) Pub Date : 2025-01-13 Jiahe Wei, Yuefeng Yu, Hanzhang Wu, Yingjun Li, Ningjian Wang, Xiao Tan
Clonal haematopoiesis of indeterminate potential (CHIP) is associated with macrovascular diseases, including coronary artery disease and stroke. However, the effects of CHIP on microvascular complication have not been evaluated in individuals with type 2 diabetes (T2D). This study included 20,712 T2D participants without prevalent diabetic microvascular complication (DMCs) and hematologic malignancy
-
Rnd3 Ameliorates Diabetic Cardiac Microvascular Injury via Facilitating Trim40-mediated Rock1 Ubiquitination Diabetes (IF 6.2) Pub Date : 2025-01-10 Jie Lin, Xuebin Zhang, Wen Ge, Yu Duan, Xiao Zhang, Yan Zhang, Xinchun Dai, Mengyuan Jiang, Xiaohua Zhang, Jiye Zhang, Huanhuan Qiang, Dongdong Sun
Diabetic microvascular dysfunction is evidenced by disrupted endothelial cell junctions and increased microvascular permeability. However, effective strategies against these injuries remain scarce. In this study, the type 2 diabetes mouse model was established by high-fat diet combined with streptozotocin injection in Rnd3 endothelial- specific transgenic and knockout mice. Echocardiography was employed
-
IP6K1 rewires LKB1 signaling to mediate hyperglycemic endothelial senescence Diabetes (IF 6.2) Pub Date : 2025-01-10 Changchang Xing, Linhui Shi, Limei Zhu, Tim Aguirre, Ji Qi, Yuanyuan Chen, Yue Liu, Alfred C. Chin, Hong Zhu, Dorothea Fiedler, Alex F. Chen, Chenglai Fu
Diabetes is a major risk factor for cardiovascular disease, but the molecular mechanisms underlying diabetic vasculopathy have been elusive. Here we report that inositol hexakisphosphate kinase 1 (IP6K1) mediates hyperglycemia-induced endothelial senescence by rewiring the liver kinase B1 (LKB1) signaling from activating the adenosine monophosphate-activated protein kinase (AMPK) pathway to the p53
-
Time-resolved effects of short-term overfeeding on energy balance in mice Diabetes (IF 6.2) Pub Date : 2025-01-09 Pablo Ranea-Robles, Camilla Lund, Charlotte Svendsen, Cláudia Gil, Jens Lund, Maximilian Kleinert, Christoffer Clemmensen
To curb the obesity epidemic, it is imperative that we improve our understanding of the mechanisms controlling fat mass and body weight regulation. While great progress has been made in mapping the biological feedback forces opposing weight loss, the mechanisms countering weight gain remain less well defined. Here, we integrate a mouse model of intragastric overfeeding with a comprehensive evaluation
-
JMJD8 regulates adipocyte hypertrophy through the interaction with Perilipin 2 Diabetes (IF 6.2) Pub Date : 2025-01-09 Dongjoo You, Sona Kang
Adipocyte hypertrophy significantly contributes to insulin resistance and metabolic dysfunction. Our previous research established JMJD8 as a mediator of insulin resistance, noting its role in promoting adipocyte hypertrophy within an autonomous adipocyte context. Nevertheless, the precise mechanisms underlying this phenomenon remained elusive. In this study, we employed a proteomics approach to identify
-
3D Imaging Resolves Human Pancreatic Duct-β-Cell Clusters During Cystic Change Diabetes (IF 6.2) Pub Date : 2025-01-09 Chih-Yuan Lee, Ting-Chun Kuo, Ya-Hsien Chou, Shih-Jung Peng, Fu-Ting Hsiao, Mei-Hsin Chung, Li-Wen Lo, Chia-Ning Shen, Hung-Jen Chien, Hsiu-Pi Chang, Chien-Chia Chen, Yung-Ming Jeng, Yu-Wen Tien, Shiue-Cheng Tang
Pancreatic cystic changes in adults are increasingly identified through advanced cross-sectional imaging. However, the impact of initial/intra-lobular epithelial remodeling on the local β-cell population remains unclear. In this study, we examined 10 human cadaveric donor pancreases (tail and body regions) via integration of stereomicroscopy, clinical H&E histology, and 3D immunohistochemistry, identifying
-
High-resolution whole-genome DNA methylation revealed unique signatures of painful diabetic neuropathy Diabetes (IF 6.2) Pub Date : 2025-01-08 Katarzyna Malgorzata Kwiatkowska, Paolo Garagnani, Massimiliano Bonafé, Maria G. Bacalini, Claudia Sala, Gastone Castellani, Davide Gentilini, Luciano Calzari, Dan Ziegler, Monique M. Gerrits, Catharina G. Faber, Rayaz A. Malik, Margherita Marchi, Erika Salvi, Giuseppe Lauria, Chiara Pirazzini
The aim of this work was to describe the DNA methylation signature and to identify genes associated with neuropathic pain in type 2 diabetes mellitus. We analyzed two independent diabetic neuropathy cohorts: PROPGER consisting of 72 painful and 67 painless patients recruited at the German Diabetes Center in Düsseldorf (DE), and PROPENG comprising 27 painful and 65 painless diabetic neuropathy patients
-
Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins Diabetes (IF 6.2) Pub Date : 2025-01-06 Tianyuan Lu, Despoina Manousaki, Lei Sun, Andrew D. Paterson
Circulating proteins may be promising biomarkers or drug targets. Leveraging genome-wide association studies of type 1 diabetes (18,942 cases and 501,638 controls of European ancestry) and circulating protein abundances (10,708 European ancestry individuals), Mendelian randomization analyses were conducted to assess the associations between circulating abundances of 1,560 candidate proteins and the
-
Effects of metformin on postprandial blood pressure, heart rate, gastric emptying, GLP-1 and the prevalence of postprandial hypotension in type 2 diabetes – a double-blind, placebo-controlled crossover study Diabetes (IF 6.2) Pub Date : 2025-01-06 Daniel R. Quast, Cong Xie, Michelle J. Bound, Jacqueline Grivell, Seva Hatzinikolas, Karen L. Jones, Michael Horowitz, Christopher K. Rayner, Michael A. Nauck, Juris J. Meier, Liza K. Phillips, Tongzhi Wu
Individuals with type 2 diabetes are at high risk of postprandial falls in blood pressure (BP) (i.e., a reduction in systolic BP of ≥20mmHg, termed postprandial hypotension (PPH)), which increases the risk of falls and mortality. This study evaluated the effects of oral metformin on postprandial BP, heart rate (HR), glucagon-like peptide-1 (GLP-1) and gastric emptying (GE) in individuals with type
-
Renal Tubule-Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes Diabetes (IF 6.2) Pub Date : 2025-01-03 Wen-Xia Yang, Ke Su, Min-Chun Liao, Jing Zhou, Junzheng Peng, Marie-Josée Hébert, Daniel N. Leal, Michifumi Yamashita, Kana N. Miyata, Janos G. Filep, Julie R. Ingelfinger, Shao-Ling Zhang, John S.D. Chan
The role of the intrarenal renin-angiotensin system (iRAS) in diabetic kidney disease (DKD) progression remains unclear. In this study, we generated mice with renal tubule-specific deletion of angiotensinogen (Agt; RT-Agt-/-) in both Akita and streptozotocin (STZ)-induced mouse model of diabetes. Both Akita RT-Agt-/- and STZ-RT-Agt-/- mice exhibited significant attenuation of glomerular hyperfiltration
-
SARS-CoV-2 Spike S1 subunit triggers pericyte and microvascular dysfunction in human pancreatic islets Diabetes (IF 6.2) Pub Date : 2024-12-23 Catarina Andrade Barboza, Luciana Mateus Gonçalves, Elizabeth Pereira, Roxana Diaz Cruz, Ruy Louzada, Maria Boulina, Joana Almaça
The COVID-19 pandemic has profoundly affected human health, yet the mechanisms underlying its impact on metabolic and vascular systems remain incompletely understood. Clinical evidence suggests that SARS-CoV-2 directly disrupts vascular homeostasis, with perfusion abnormalities observed in various tissues. The pancreatic islet, a key endocrine mini-organ reliant on its microvasculature for optimal
-
Blood-based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes. Diabetes (IF 6.2) Pub Date : 2024-12-23 Marian Marchiori, Alice Maguolo, Alexander Perfilyev, Marlena Maziarz, Mats Martinell, Maria F. Gomez, Emma Ahlqvist, Sonia García-Calzón, Charlotte Ling
There is an increasing need for new biomarkers improving prediction of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D). We aimed to identify blood-based epigenetic biomarkers associated with incident CKD and develop a methylation risk score (MRS) predicting CKD in newlydiagnosed individuals with T2D. DNA methylation was analysed epigenome-wide in blood from 487 newly-diagnosed
-
Extracellular Mitochondria Exacerbate Retinal Pigment Epithelium Degeneration in Diabetic Retinopathy Diabetes (IF 6.2) Pub Date : 2024-12-23 Keiichi Nishikawa, Tomoaki Murakami, Miyo Yoshida, Noriko Terada, Kenji Ishihara, Yuki Mori, Shinji Ito, Akitaka Tsujikawa
Advances in fundus imaging are revealing disruptions in the neurovascular unit in diabetic retinopathy (DR). In the era of anti-VEGF treatment, a thorough characterization of neurodegeneration is imperative until DR patients are sufficiently cured. Here we demonstrate that extracellular mitochondria exacerbate retinal pigment epithelium (RPE) degeneration and inflammation in DR. Extracellular mitochondria
-
Loss of β-cell KATP reduces Ca2+ sensitivity of insulin secretion and Trpm5 expression Diabetes (IF 6.2) Pub Date : 2024-12-12 Nathaniel W. York, Zihan Yan, Anna B. Osipovich, Abbie Tate, Sumit Patel, David W. Piston, Mark A. Magnuson, Maria S. Remedi, Colin G. Nichols
Loss-of-function (LOF) mutations in KATP channels cause hyperexcitability and insulin hypersecretion, resulting in congenital hyperinsulinism (CHI). Paradoxically, despite the initial insulin hypersecretion, many CHI cases, as well as KATP knockout (KO) animals, eventually ‘crossover’ to undersecretion and even diabetes. Here we confirm that Sur1 KO islets exhibit higher intracellular [Ca2+] ([Ca2+]i)
-
Adipose tissue biology and effect of weight loss in women with lipedema Diabetes (IF 6.2) Pub Date : 2024-12-09 Vincenza Cifarelli, Gordon I. Smith, Silvia Gonzalez-Nieves, Dmitri Samovski, Hector H. Palacios, Jun Yoshino, Richard I. Stein, Anja Fuchs, Thomas F. Wright, Samuel Klein
Lipedema is a lipodystrophic disease that is typically characterized by a marked increase in lower-body subcutaneous adipose tissue that is purported to have increased inflammation and fibrosis, impaired microvascular/lymphatic circulation and to be resistant to reduction by weight loss therapy. However, these outcomes have not been adequately studied. We evaluated body composition, insulin sensitivity
-
Gain of function NOTCH3 variants cause familial partial lipodystrophy due to activation of senescence pathways Diabetes (IF 6.2) Pub Date : 2024-12-09 Abhimanyu Garg, Chao Xing, Anil K. Agarwal, Aundrea K. Westfall, Diana R. Tomchick, Xunzhi Zhang, Michelle Xing, Rebecca J. Brown
Despite elucidation of the molecular genetic basis of several lipodystrophy syndromes, molecular defects in some ultra-rare subtypes of familial lipodystrophies remain unidentified. We analyzed whole exome sequencing (WES) data of four affected and two unaffected females from an undiagnosed autosomal dominant familial partial lipodystrophy (FPL) pedigree and identified only one novel heterozygous variant
-
β-Cell Secretory Capacity Predicts Metabolic Outcomes over 6 Years following Human Islet Transplantation Diabetes (IF 6.2) Pub Date : 2024-12-04 Anneliese J. Flatt, Austin M. Matus, Robert J. Gallop, Eileen Markmann, Cornelia Dalton-Bakes, Amy J. Peleckis, Chengyang Liu, Ali Naji, Michael R. Rickels
Transplanted islet functional β-cell mass is measured by the β-cell secretory capacity derived from the acute insulin response to glucose-potentiated arginine (AIRpot), however, data are limited beyond one-year post-transplant for individuals with type 1 diabetes. We evaluated changes in β-cell secretory capacity in a single-center longitudinal analysis and examined relationships with measures of islet
-
Plasma proteomic signatures of adiposity are associated with cardiovascular risk factors and type 2 diabetes risk in a multi-ethnic Asian population. Diabetes (IF 6.2) Pub Date : 2024-12-02 Charlie G.Y. Lim, Bige Ozkan, Yujian Liang, Jingsha Chen, Jiali Yao, Nang Ei Ei Khaing, Mary R. Rooney, Chiadi E. Ndumele, E Shyong Tai, Josef Coresh, Xueling Sim, Rob M. van Dam
The biomarkers connecting obesity and cardiometabolic diseases are not fully understood. We aimed to (i) evaluate the associations between body mass index (BMI), waist circumference (WC), and ∼5,000 plasma proteins (SomaScan v4), (ii) identify protein signatures of BMI and WC, and (iii) evaluate the associations between the protein signatures and cardiometabolic health including metabolically unhealthy
-
Blocking adipocyte YY1 decouples thermogenesis from beneficial metabolism by promoting spermidine production Diabetes (IF 6.2) Pub Date : 2024-12-02 Chen Qiu, Yu Lu, Suyang Wu, Wenli Guo, Jiahao Ni, Jiyuan Song, Zichao Liu, Xiaoai Chang, Kai Wang, Peng Sun, Qian Zhang, Shufang Yang, Kai Li
The accumulation of mitochondria in thermogenic adipose tissue (i.e., brown and beige fat) increases energy expenditure, which can aid in alleviating obesity and metabolic disorders. However, recent studies have shown that knocking out key proteins required to maintain mitochondrial function inhibits the energy expenditure in thermogenic fat, and yet the knockout mice are unexpectedly protected from
-
Imaging human pancreatic endocrinogenesis during early prenatal life Diabetes (IF 6.2) Pub Date : 2024-11-27 Adrian Villalba, Yorick Gitton, Virginie Aiello, Maryne Toupin, Séverine Mazaud-Guittot, Alain Chédotal, Raphaël Scharfmann
Murine pancreatic endocrinogenesis has been extensively studied, but human data remain scarce due to limited sample availability. Here, we first built a large collection of human embryonic and fetal pancreases covering the first trimester of pregnancy to explore human endocrinogenesis. Using an experimental pipeline combining in toto staining, tissue clearing, and light-sheet fluorescence microscopy
-
Improved Afternoon Hepatic Glucose Disposal and Storage Requires Morning Engagement of Hepatic Insulin Receptors Diabetes (IF 6.2) Pub Date : 2024-11-27 Hannah L. Waterman, Mary Courtney Moore, Marta S. Smith, Ben Farmer, Kalisha Yankey, Melanie Scott, Dale S. Edgerton, Alan D. Cherrington
Glucose tolerance improves significantly upon consuming a second, identical meal later in the day (second meal phenomenon). We previously established that morning hyperinsulinemia primes the liver for increased afternoon hepatic glucose uptake (HGU). Although the route of insulin delivery is an important determinant of the mechanisms by which insulin regulates liver glucose metabolism (direct hepatic
-
Ablation of FAM210A in brown adipocytes of mice exacerbates high fat diet induced metabolic dysfunction Diabetes (IF 6.2) Pub Date : 2024-11-27 Jiamin Qiu, Mennatallah A. Khedr, Meijin Pan, Christina R. Ferreira, Jingjuan Chen, Madigan M. Snyder, Kolapo M. Ajuwon, Feng Yue, Shihuan Kuang
Thermogenesis of brown adipose tissues (BAT) provides metabolic benefits against pathological conditions such as Type 2 diabetes, obesity, cardiovascular diseases, and cancer. The thermogenic function of BAT relies on mitochondria, but whether mitochondrial remodeling is required for the beneficial effects of BAT remains unclear. We have recently identified FAM210A as a BAT-enriched mitochondrial protein
-
Resolving spatiotemporal electrical signaling within the islet via CMOS microelectrode arrays Diabetes (IF 6.2) Pub Date : 2024-11-25 Anne Gresch, Jana Osthues, Jan D. Hüwel, Jennifer K. Briggs, Tim Berger, Ruben Koch, Thomas Deickert, Christian Beecks, Richard K.P. Benninger, Martina Düfer
Glucose-stimulated beta-cells exhibit synchronized calcium dynamics across the islet that recruit beta-cells to enhance insulin secretion. Compared to calcium dynamics, the formation and cell-to-cell propagation of electrical signals within the islet are poorly characterized. To determine factors that influence the propagation of electrical activity across the islet underlying calcium oscillations
-
The IsletTester mouse: an immunodeficient model with stable hyperglycemia for the study of human islets Diabetes (IF 6.2) Pub Date : 2024-11-21 Eric L. Waite, Mark Tigue, Ming Yu, Deeksha Lahori, Kai Kelly, Catherine Lee May, Ali Naji, Jeffrey Roman, Nicolai Doliba, Dana Avrahami, Kim-Vy Nguyen-Ngoc, Maike Sander, Benjamin Glaser, Klaus H. Kaestner
The gold standard for assessing the function of human islets or β-like cells derived from stem cells involves their engraftment under the kidney capsule of hyperglycemic, immunodeficient mice. Current models, such as Streptozotocin (STZ) treatment of severely immunodeficient mice or the NRG-Akita strain are limited due to unstable and variable hyperglycemia and/or high morbidity of these models. To
-
Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes Diabetes (IF 6.2) Pub Date : 2024-11-21 Sky T. H. Ng, Michael J. Price, Naomi Richardson, Maher Nawaf, Alastair Copland, Heather B. Streeter, Parth Narendran, David C. Wraith
Dysregulation and loss of immune tolerance towards pancreatic β-cell autoantigens are features of type 1 diabetes (T1D). Until recently, life-long insulin injection was the only approved treatment for T1D, and this does not address the underlying disease pathology. Antigen-specific immunotherapy (ASI) seeks to restore tolerance and holds potential as a new therapeutic strategy for treating autoimmune
-
Tracking insulin- and glucagon-expressing cells in vitro and in vivo using a double reporter human embryonic stem cell line Diabetes (IF 6.2) Pub Date : 2024-11-19 Samantha Mar, Ekaterina Filatov, Shugo Sasaki, Majid Mojibian, Dahai Zhang, Angela Yang, Cuilan Nian, Francis C. Lynn
Human embryonic stem cell (hESC)-derived pancreatic alpha and beta cells can be used to develop cell replacement therapies to treat diabetes. However, recent published differentiation protocols yield varying amounts of alpha and beta cells amidst heterogeneous cell populations. To visualize and isolate hESC-derived alpha and beta cells, we generated a GLUCAGON-2AmScarlet and INSULIN-2A-EGFP dual fluorescent
-
Proteomic Signature of Body Mass Index and Risk of Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2024-11-19 Xuan Wang, Hao Ma, Minghao Kou, Yoriko Heianza, Vivian Fonseca, Lu Qi
The obesity diagnosis by body mass index (BMI) exhibits considerable interindividual heterogeneity in metabolic phenotypes and risk of developing type 2 diabetes (T2D). We investigated the association of proteomic signature of BMI and T2D and examined whether the proteomic signature of BMI improves prediction of T2D risk. This study included 41,427 adults in the UK Biobank who were free of T2D at baseline
-
Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes Diabetes (IF 6.2) Pub Date : 2024-11-19 Sevilay Tokgöz, Marti Boss, Theodorus JP Jansen, Rick Meijer, Cathelijne Frielink, Arianne C van Bon, Cees J Tack, Bastiaan E de Galan, Martin Gotthardt
Glucagon-like peptide 1 receptor (GLP-1R) agonists fail to reduce weight and improve glucose control in a sizable minority of people with type 2 diabetes. We hypothesized that stimulation of the hypothalamic-pituitary-adrenal (HPA) axis by GLP-1R agonists, thus inducing cortisol secretion, could explain this unresponsiveness to GLP-1R agonists. To assess the effects of GLP-1R agonist treatment on the
-
Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes Diabetes (IF 6.2) Pub Date : 2024-11-18 Delnaz Roshandel, Athina Spiliopoulou, Stuart J. McGurnaghan, Andrii Iakovliev, Debby Lipschutz, Caroline Hayward, Shelley B. Bull, Barbara E.K. Klein, Kris E. Lee, Gregory L. Kinney, Marian Rewers, Tina Costacou, Rachel G. Miller, Paul M. McKeigue, Andrew D. Paterson, Helen M. Colhoun
Identified genetic loci for C-peptide and age at diagnosis (AAD) in individuals with type 1 diabetes (T1D) explain only a small proportion of their variation. Here, we aimed to perform large metagenome-wide association studies (GWAS) of C-peptide and AAD in T1D; and to identify the HLA allele/haplotypes associated with C-peptide and AAD. 7,252 and 7,923 European individuals with T1D were included in
-
Stopping the intergenerational risk of diabetes – from mechanisms to interventions Diabetes (IF 6.2) Pub Date : 2024-11-18 Soren Harnois-Leblanc, Marie-France Hivert
Embedded in the Developmental Origins of Health and Disease hypothesis, maternal hyperglycemia in utero, from pre-existing diabetes or gestational diabetes mellitus, predisposes the offspring to excess adiposity and heightened risk of prediabetes and type 2 diabetes development. This transmission creates a vicious cycle increasing the presence of diabetes from one generation to another, leading to
-
Diabetes Mellitus Associated with Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype Diabetes (IF 6.2) Pub Date : 2024-11-18 Jean-Pierre Chanoine, David M Thompson, Anna Lehman
Maternally inherited diabetes and deafness (MIDD) is a monogenic mitochondrial disorder caused by a pathogenic variant in the MT-TL1 gene encoding for a leucine transfer RNA. We propose a new hypothesis that explains how the MT-TL1 variant causes impaired glucose tolerance and diabetes in MIDD. We suggest that diabetes in MIDD primarily depends on a variable combination of insulin resistance and impaired
-
Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6 Diabetes (IF 6.2) Pub Date : 2024-11-18 Dudley H. McNitt, Jonathan M. Williams, Joseph G. Santitoro, Jacob Kim, James W. Thomas, Rachel H. Bonami
High-affinity islet autoantibodies predict type 1 diabetes in mice and humans and implicate germinal centers (GCs) in type 1 diabetes pathogenesis. T follicular helper (Tfh) cells are increased in type 1 diabetic individuals and alterations in Tfh-like cells in the peripheral blood predicted individual responses to abatacept. Tfh cells support GC responses and depend on the transcriptional repressor
-
Identification of Metabolic Patterns in Korean Patients with Type 2 Diabetes Mellitus and their Association with Diabetes-Related Complications Diabetes (IF 6.2) Pub Date : 2024-11-15 Minji Kang, Kumhee Son, You-Cheol Hwang, Sihoon Lee, Hyunji Sang, Sunyoung Kim, Dong Keon Yon, Sang Youl Rhee, Hyunjung Lim
Resolving metabolic heterogeneity in patients with type 2 diabetes mellitus (T2DM) gives them access to precision medicine. Despite ethnic diversity in pathophysiological processes in individuals with T2DM, studies on subtypes of diabetes related to clinical characteristics in Asians are insufficient. This study aims to identify metabolic patterns in middle-aged patients with T2DM in Republic of Korea
-
Increased COX6A2 promotes pancreatic β-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass Diabetes (IF 6.2) Pub Date : 2024-11-15 Xiangchen Kong, Dan Yan, Lianqi Shao, Bingfeng Li, Simian Lv, Yifan Tu, Yingqi Zhang, Xingsheng Shu, Ying Ying, Xiaosong Ma
Roux-en-Y gastric bypass (RYGB) has been shown to inhibit β-cell apoptosis, but the underlying mechanisms are not yet fully understood. Cytochrome c oxidase subunit 6A2 (COX6A2) is expressed in β-cells. Here, we sought to investigate the role of COX6A2 in β-cell apoptosis, especially following RYGB. We found that RYGB significantly reduced β-cell apoptosis, accompanied by decreased COX6A2 expression
-
Friend or foe: the paradoxical roles of MG53 in diabetes mellitus Diabetes (IF 6.2) Pub Date : 2024-11-13 Shuangshuang Yuan, Qin Yu, Mao Luo, Jianbo Wu, Liqun Wang
MG53 is predominantly expressed in striated muscles. The role of MG53 in diabetes mellitus has been gradually elucidated but is still full of controversy. Some reports have indicated that MG53 is upregulated in animal models with metabolic disorders, and that muscle-specific MG53 upregulation is sufficient to induce whole-body insulin resistance and metabolic syndrome through targeting both the insulin
-
Innovating Diabetes Care in Pregnancy: Do group care models improve outcomes and equity? Diabetes (IF 6.2) Pub Date : 2024-11-12 Ebony B. Carter
Shared medical appointments (SMAs) for diabetes and group prenatal care (GPC) for pregnant patients, have emerged as innovative care delivery models. They have the potential to transform diabetes care by overcoming many of the time limitations of traditional one-on-one clinical visits. There is compelling evidence that SMAs improve glycemic control for non-pregnant patients with diabetes, GPC reduces
-
The effect of small increases in blood glucose on insulin secretion and endogenous glucose production in humans Diabetes (IF 6.2) Pub Date : 2024-11-07 Clinton R. Bruce, Teddy Ang, Jason D. Toms, Giang M. Dao, Jean Liu, Glenn M. Ward, David N. O’Neal, Dale J. Morrison, Greg M. Kowalski
Small glycemic increments (≤0.5 mmol/L) can exert suppressive actions on endogenous glucose production (EGP) however it is unclear if this is an insulin dependent or independent process. Here, we performed a low-rate glucose infusion in control participants without diabetes and in people with type 1 diabetes (T1D) to better understand this phenomenon. Glucose kinetics, hormones and metabolites were
-
Nicotinic signaling stimulates glucagon secretion in mouse and human pancreatic α-cells Diabetes (IF 6.2) Pub Date : 2024-10-30 Alexander Hamilton, Quan Zhang, Rui Gao, Thomas Hill, Albert Salehi, Jakob G. Knudsen, Matthew Draper, Paul R.V. Johnson, Patrik Rorsman, Andrei I. Tarasov
Smoking is widely regarded as a risk factor for type 2 diabetes, as nicotine contributes to insulin resistance by desensitizing the insulin receptors in muscle, liver, or fat. Little is known, however, about the immediate regulation of islet hormonal output by nicotine, an agonist of ionotropic cholinergic receptors. We investigated this by imaging cytosolic Ca2+ dynamics in mouse and human islets
-
N 6-Methyladenosine demethylase FTO controls macrophage homeostasis in diabetic vasculopathy Diabetes (IF 6.2) Pub Date : 2024-10-24 Siguo Feng, Qiuyang Zhang, Qing Liu, Chang Huang, Huiying Zhang, Fengsheng Wang, Yue Zhu, Qizhi Jian, Xue Chen, Qin Jiang, Biao Yan
Diabetic vasculopathy, encompassing complications such as diabetic retinopathy, represents a significant source of morbidity, with inflammation playing a pivotal role in the progression of these complications. This study investigates the influence of m6A modification and the m6A demethylase FTO on macrophage polarization and its subsequent effects on diabetic microvasculopathy. We found that diabetes
-
Induction of a Müller glial-specific protective pathway safeguards the retina from diabetes induced damage Diabetes (IF 6.2) Pub Date : 2024-10-24 Cheng-Hui Lin, Man-Ru Wu, Bogdan Tanasa, Praveen Prakhar, Boxiong Deng, Alexander E. Davis, Liang Li, Alexander Xia, Yang Shan, Patrice E. Fort, Sui Wang
Diabetes can lead to cell-type-specific responses in the retina, including vascular lesions, glial dysfunction and neurodegeneration, all of which contribute to retinopathy. However, the molecular mechanisms underlying these cell type-specific responses, and the cell types that are sensitive to diabetes have not been fully elucidated. Employing single cell transcriptomics, we profiled the transcriptional
-
Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future Diabetes (IF 6.2) Pub Date : 2024-10-24 Roberto Mallone, Emily Sims, Peter Achenbach, Chantal Mathieu, Alberto Pugliese, Mark Atkinson, Sanjoy Dutta, Carmella Evans-Molina, David Klatzmann, Anne Koralova, S. Alice Long, Lut Overbergh, Teresa Rodriguez-Calvo, Anette-Gabriele Ziegler, Sylvaine You
Type 1 diabetes treatment stands at a crucial and exciting crossroad since the 2022 U.S. Food and Drug Administration (FDA) approval of teplizumab to delay disease development. In this Perspective article, we discuss four major conceptual and practical issues that emerged as key to further advance type 1 diabetes research and therapies. First, collaborative networks leveraging the synergy between the
-
Long-term nerve regeneration in diabetic keratopathy mediated by a novel NGF delivery system Diabetes (IF 6.2) Pub Date : 2024-10-24 Lin Cong, Benxiang Qi, Shijiu Chen, Ruiling Liu, Suxia Li, Qingjun Zhou, Yihai Cao, Bi Ning Zhang, Lixin Xie
Diabetic keratopathy (DK) is a common chronic metabolic disorder that causes ocular surface complications. Among various therapeutic approaches, local delivery of nerve growth factor (NGF) remains the most effective treatment for DK. However, achieving a sustained therapeutic effect with NGF and the frequent drug delivery burden remain challenging during clinical practice. Here, we developed a novel
-
Effect of Hyperketonemia on Myocardial Function in Patients with Heart Failure and Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-24 Carolina Solis-Herrera, Yuejuan Qin, Henri Honka, Eugenio Cersosimo, Curtis Triplitt, Sivaram Neppala, Jemena Rajan, Francisca M. Acosta, Alexander J. Moody, Patricio Iozzo, Peter Fox, Geoffrey Clarke, Ralph A. DeFronzo
We examined the effect of increased plasma ketones on left ventricular (LV) function, myocardial glucose uptake (MGU), and myocardial blood flow (MBF) in type 2 diabetes (T2DM) patients with heart failure (HF). Three groups (I,II,III) of T2DM (12 per group) with LV ejection fraction ≤50% received incremental infusions of β-OH-B for 3-6 hours to raise plasma β-OH-B concentration throughout the physiologic
-
IER3IP1 mutations cause neonatal diabetes due to impaired proinsulin trafficking Diabetes (IF 6.2) Pub Date : 2024-10-23 Hossam Montaser, Sonja Leppänen, Eliisa Vähäkangas, Nils Bäck, Alicia Grace, Solja Eurola, Hazem Ibrahim, Väinö Lithovius, Samuel B. Stephens, Tom Barsby, Diego Balboa, Jonna Saarimäki-Vire, Timo Otonkoski
Immediate early response 3 interacting-protein 1 (IER3IP1) is an endoplasmic reticulum resident protein, highly expressed in pancreatic cells and the developing brain cortex. Homozygous mutations in IER3IP1 have been found in individuals with microcephaly and neonatal diabetes, yet the underlying mechanism causing beta cell failure remains unclear. Here, we utilized differentiation of genome edited-stem
-
Neurodevelopmental Pathways to Obesity and Type 2 Diabetes: Insights From Prenatal Exposure to Maternal Obesity and Gestational Diabetes Mellitus: A Report on Research Supported by Pathway to Stop Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-21 Kathleen A. Page
Incidences of childhood obesity and type 2 diabetes (T2D) are climbing at alarming rates. Evidence points to prenatal exposures to maternal obesity and gestational diabetes mellitus (GDM) as key contributors to these upward trends. Children born to mothers with these conditions face higher risks of obesity and T2D, beyond genetic or shared environmental factors. The underpinnings of this maternal-fetal
-
Multi-Omics Mendelian Randomization Study Investigating the Impact of PCSK9 and HMGCR Inhibition on Type 2 Diabetes Across Five Populations Diabetes (IF 6.2) Pub Date : 2024-10-17 Daniel B. Rosoff, Josephin Wagner, Jeesun Jung, Pal Pacher, Constantinos Christodoulides, George Davey Smith, David Ray, Falk W. Lohoff
The prevalence of type 2 diabetes (T2D) varies among populations of different race/ethnicity. The influence of genetically-proxied lipoprotein cholesterol (LDL-C) lowering through proprotein convertase subtilisin/kexin 9 (PCSK9) and HMG-CoA Reductase (HMGCR) on T2D in non-European populations is not well established.A drug-target Mendelian randomization (MR) approach was used to assess the effects
-
When does metabolic memory start? Insights from the AMD Annals Initiative on stringent HbA1c targets. Diabetes (IF 6.2) Pub Date : 2024-10-17 Giuseppina T. Russo, Antonio Nicolucci, Giuseppe Lucisano, Maria Chiara Rossi, Antonio Ceriello, Francesco Prattichizzo, Valeria Manicardi, Alberto Rocca, Paolo Di Bartolo, Salvatore De Cosmo, Graziano Di Cianni, Riccardo Candido
Early, intensive glycemic control in T2D patients is associated with long-term benefits on cardiovascular disease (CVD) development. Evidence on benefits of achieving HbA1c targets close to normal values is scant. Subjects with newly-diagnosed T2D, without CVD at baseline, were identified in an Italian clinical registry (N=251,339). We adopted three definitions of early exposure periods (0–1, 0–2 and
-
Exploring Structural and Molecular Features of Sciatic Nerve Lesions in Diabetic Neuropathy: Unveiling Pathogenic Pathways and Targets Diabetes (IF 6.2) Pub Date : 2024-10-17 Daniel Schwarz, Maxime Le Marois, Volker Sturm, Andreas S. Peters, Rémi Longuespée, Dominic Helm, Martin Schneider, Bastian Eichmüller, Asa S. Hidmark, Manuel Fischer, Zoltan Kender, Constantin Schwab, Ingrid Hausser, Joachim Weis, Susanna Dihlmann, Dittmar Böckler, Martin Bendszus, Sabine Heiland, Stephan Herzig, Peter P. Nawroth, Julia Szendroedi, Thomas Fleming
Lesioned fascicles (LF) in the sciatic nerves of individuals with diabetic neuropathy (DN) correlate with clinical symptom severity. This study aimed to characterize the structural and molecular composition of these lesions to better understand DN pathogenesis. Sciatic nerves from amputees with and without type 2 diabetes (T2D) were examined using ex vivo magnetic resonance neurography, in vitro imaging
-
1-hour postload glucose is a more sensitive marker of impaired β-cell function than 2-hour postload glucose Diabetes (IF 6.2) Pub Date : 2024-10-17 Jingyi Lu, Jiaying Ni, Hang Su, Xingxing He, Wei Lu, Wei Zhu, Yufei Wang, Xiaojing Ma, Yuqian Bao, Jian Zhou
There is evidence that 1-h plasma glucose (PG) during the 75-g oral glucose tolerance test (OGTT) is superior to 2-h PG in predicting diabetes. We aimed to investigate the characteristics of insulin sensitivity and β-cell function behind this observation. After age, sex and BMI matching, 496 subjects selected from 3965 non-diabetic individuals at high risk of type 2 diabetes in a tertiary medical center
-
Functionally Separate Populations of Ventromedial Hypothalamic Neurons in Obesity and Diabetes Diabetes (IF 6.2) Pub Date : 2024-10-17 Jonathan N. Flak
The Ventromedial hypothalamic nucleus (VMN) maintains healthy metabolic function through several important roles. Collectively, homeostasis is maintained via intermingled cells within the VMN that raise blood glucose, lower blood glucose, and stimulate energy expenditure when needed. This perspective discusses the defining factors for the VMN cell types that govern distinct functions induced by the
-
Evaluating the causal effect of circulating proteome on the glycemic traits: Evidence from Mendelian randomization Diabetes (IF 6.2) Pub Date : 2024-10-17 Xing Xing, Siqi Xu, Yining Wang, Ziyuan Shen, Simin Wen, Yan Zhang, Guangfeng Ruan, Guoqi Cai
Exploring the mechanisms underlying abnormal glycemic traits is important for deciphering type 2 diabetes and characterizing novel drug targets. This study aimed to decipher the causal associations of circulating proteins with fasting glucose (FG), 2-h glucose after an oral glucose challenge (2hGlu), fasting insulin (FI), and glycated hemoglobin (HbA1c) using large-scale proteome-wide Mendelian randomization